9th June 2020
- 0 comments
Qkine, a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications, has closed a £1.5 million series A investment round to accelerate the global scale-up of its commercial operations and make key hires to its leadership team. The funding round attracted support from a wealth of leading life science funds and angel investors, including Parkwalk, a London-based firm that backs world-changing technologies emerging from the UK’s leading universities, who led the round; Jonathan Milner, serial entrepreneur and founder of Abcam; Martlet Capital, a Cambridge-based investor with a growing portfolio of innovative life science companies; and the fast-growing o2h ventures Human Health EIS fund.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.